APC gene testing for familial adenomatosis polyposis.
作者信息
Roy Hemant K, Khandekar Janardan D
出版信息
JAMA. 2012 Aug 1;308(5):514-5. doi: 10.1001/jama.2012.9516.
Abstract
摘要
相似文献
1
APC gene testing for familial adenomatosis polyposis.
JAMA. 2012 Aug 1;308(5):514-5. doi: 10.1001/jama.2012.9516.
2
Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
JAMA. 2012 Aug 1;308(5):485-492. doi: 10.1001/jama.2012.8780.
3
High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis.
Gastroenterology. 2004 Jun;126(7):1681-5. doi: 10.1053/j.gastro.2004.02.022.
4
Presentation and Follow-up of Familial Adenomatous Polyposis: Differences Between APC and MUTYH Mutations.
Cir Esp (Engl Ed). 2020 Oct;98(8):465-471. doi: 10.1016/j.ciresp.2020.04.033. Epub 2020 Jun 3.
5
APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
Clin Genet. 2009 Sep;76(3):242-55. doi: 10.1111/j.1399-0004.2009.01241.x.
6
MutYH-associated polyposis.
Ter Arkh. 2019 Mar 18;91(2):97-100. doi: 10.26442/00403660.2019.02.000124.
7
Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.
Eur J Hum Genet. 2015 Feb;23(2):260-3. doi: 10.1038/ejhg.2014.74. Epub 2014 May 7.
8
Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - update 2012.
Eur J Hum Genet. 2013 Jan;21(1). doi: 10.1038/ejhg.2012.163. Epub 2012 Aug 8.
9
Attenuated polyposis of the large bowel: a morphologic and molecular approach.
Fam Cancer. 2017 Apr;16(2):211-220. doi: 10.1007/s10689-016-9938-9.
10
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2954-8. doi: 10.1073/pnas.042699199. Epub 2002 Feb 26.
引用本文的文献
1
Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.
Cancers (Basel). 2020 Mar 28;12(4):812. doi: 10.3390/cancers12040812.
本文引用的文献
1
Molecular biology. Genetic events that shape the cancer epigenome.
Science. 2012 Jun 22;336(6088):1513-4. doi: 10.1126/science.1223730.
2
Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization.
Cancer Res. 2012 Jun 1;72(11):2720-7. doi: 10.1158/0008-5472.CAN-11-3807. Epub 2012 Apr 6.
3
Deep intronic APC mutations explain a substantial proportion of patients with familial or early-onset adenomatous polyposis.
Hum Mutat. 2012 Jul;33(7):1045-50. doi: 10.1002/humu.22082. Epub 2012 Apr 16.
4
Proteomic consequences of a single gene mutation in a colorectal cancer model.
J Proteome Res. 2012 Feb 3;11(2):1184-95. doi: 10.1021/pr2009109. Epub 2011 Dec 13.
5
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
JAMA. 2011 Jun 8;305(22):2304-10. doi: 10.1001/jama.2011.743.
6
Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia.
N Engl J Med. 2010 Dec 30;363(27):2628-37. doi: 10.1056/NEJMoa1006565.
7
Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening.
Gastroenterology. 2011 Jan;140(1):35-41. doi: 10.1053/j.gastro.2010.11.023. Epub 2010 Nov 12.
8
Hereditary and familial colon cancer.
Gastroenterology. 2010 Jun;138(6):2044-58. doi: 10.1053/j.gastro.2010.01.054.
9
Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.
Clin Gastroenterol Hepatol. 2007 Jun;5(6):736-42. doi: 10.1016/j.cgh.2007.02.019.
10
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7.
Zotero 插件